Drug Development Project
The Drug Development Project provides in-kind support—managed by CRUK’s Centre for Drug Development—to advance novel cancer therapeutics from preclinical development through early-phase patient trials, with no external grant funding.
Eligibility Criteria:
-
Agent origin: Novel cancer agent (small molecule, biologic or other modality) with supporting in vivo efficacy data
-
Applicant type:
-
Academic researchers at UK institutions
-
Pharmaceutical or biotech companies (UK or international)
-
-
Prior engagement: Must have discussed proposal suitability with CRUK’s Centre for Drug Development (CDD)
How to Apply & Further Information:
-
Discuss suitability: Contact CDD at [email protected] with a brief outline and data summary
-
Confidential review: If required, sign a CDA; CDD will advise readiness for formal application
-
Formal application: Submit your full data package via Flexi-Grant
-
Committee meeting: Present to the New Agents Committee (in-person or online)
-
Decision: Receive outcome within two weeks
Contact:
Kate Searle, Research Funding Manager
Email: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023